Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Natural History Study for the ASXL-Related Disorders and Chromatinopathies

NCT03303716 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT03303716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03303716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Natural History Study for the ASXL-Related Disorders and Chromatinopathies
Lead sponsor
University of California, Los Angeles
Phase
Observational
Overall status
Recruiting
Start date
September 20, 2017
Completion date
September 30, 2037
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asxl1 gene mutation, asxl2 gene mutation, asxl3 gene mutation, bainbridge-ropers syndrome, bohring-opitz syndrome, shashi-pena syndrome